AcesoStem Biostrategies
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $4.3M
Investors
- 5
About AcesoStem Biostrategies
Based in Seoul, South Korea, and founded in 2019 by Professor Hyuncheol Cho, AcesoStem Biostrategies operates as a research and development company that develops therapies for intractable musculoskeletal disorders. AcesoStem Biostrategies developing therapy based on smump cell is an umbilical cord-derived cell without aging and low immunogenicity and high immunomodulatory ability even in a pro-inflammatory lesion environment. It also develops cell tuning technology, including conditioning technology for cells and lesions.
Who invested in AcesoStem Biostrategies
5 investors across 2 rounds
See all investors in AcesoStem Biostrategies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AcesoStem Biostrategies
Who invested in AcesoStem Biostrategies?
AcesoStem Biostrategies has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AcesoStem Biostrategies raised?
AcesoStem Biostrategies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AcesoStem Biostrategies last raise money?
AcesoStem Biostrategies's most recent round on record is a Series A, in Jun 2026.
What does AcesoStem Biostrategies do?
Based in Seoul, South Korea, and founded in 2019 by Professor Hyuncheol Cho, AcesoStem Biostrategies operates as a research and development company that develops therapies for intractable musculoskeletal disorders.
Where is AcesoStem Biostrategies headquartered?
AcesoStem Biostrategies is headquartered in Seoul, South Korea.
Which VCs invest in companies like AcesoStem Biostrategies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at AcesoStem Biostrategies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AcesoStem Biostrategies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.